Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol oral THC safety and tolerability in healthy elderly subjects
NL-OMON37093Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sodium oxybate (4 arms), sponsored by Radboud University Medical Center. Primary endpoint: Safety and tolerability of three oral doses of Namisol. Started Aug 2012; status: active, not recruiting.
02
Drugs
sodium oxybate
Beyond the preview
Go deeper on NL-OMON37093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37093.